8+ hour, 13+ min ago  (639+ words) by LISA FLETCHER, ANDREA NEJMAN, NATHAN AARON | Spotlight on America NEW HAVEN, Ct. (SOA) " For years we've been investigating poorly made generic drugs, but now, a new chapter: What if the same problems we've been reporting on could affect the…...

9+ hour, 14+ min ago  (187+ words) 19 May 2026 | Tuesday | News This expanded collaboration extends beyond manufacturing, bringing together Ottimo Pharma and LOTTE Biologics to advance Ottimo Pharma's promising biparatopic antibody, OTP-01, toward launch readiness. Lotte's development team at the Syracuse Bio Campus in New York, will support…...

7+ hour, 46+ min ago  (1032+ words) - Research Describes the Potential of JCR's Platform Technologies, Including JUST-AAV Gene Therapy, to Facilitate Delivery of Therapies to the Central Nervous System -HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals Co. , Ltd. (TSE 4552; "JCR), a global specialty biopharmaceutical company dedicated to developing…...

1+ hour, 18+ min ago  (1150+ words) Invion is tackling a difficult eye disease that defeated Opthea, big time. But will its approach prove to be visionary? Pic: Getty Images Cancer drug developer Invion (ASX: IVX) has turned to the non-oncology ophthalmology sector, via a collaboration to tackle…...

3+ hour, 11+ min ago  (11+ words) the-sun. com...

5+ hour, 35+ min ago  (257+ words) T cell-based therapies, including CAR-T cells and bispecific antibodies, have transformed outcomes for patients with multiple myeloma, a cancer of plasma cells in the bone marrow. However, many patients eventually relapse, in part because their T cells become "exhausted" and…...

1+ hour, 18+ min ago  (548+ words) As teplizumab opens the door to disease-modifying treatment, researchers say the next era of type 1 diabetes care may depend on protecting beta cells, calming autoimmune attack, and finding patients early enough to change the disease trajectory. Review: New and emerging…...

2+ hour, 17+ min ago  (184+ words) The company's lead program targets knee osteoarthritis, a condition affecting more than 32 million Americans. Wonderlab Bio is developing an injectable i PSC-derived chondrocyte therapy aimed at regenerating cartilage without surgery. The company said the treatment is expected to cost less…...

2+ hour, 23+ min ago  (157+ words) Flu and Chickenpox Vaccines Receive Compliance Certification Achieves Cost Savings of More Than 50% GC Biopharma said Thursday it has obtained final approval from the World Health Organization (WHO) after the regulator's regular Good Manufacturing Practice (GMP) on-site inspection was replaced…...

1+ hour, 33+ min ago  (430+ words) The Crisafulli Government has lured Victoria-based Clinical Trial Group to set up shop in Queensland, investing $11. 2 million through the flagship $180. 6 million Sovereign Industry Development Fund. Clinical Trials Group will expand into Queensland with the establishment of a new 40+ bed Phase…...